Main > ONCOLOGY (**) > Lymphoma>NHL>B-Cell>MCL > Treatment > USA. G. Brexucabtagene Autoleucel>

---

USA. G. Brexucabtagene Autoleucel>'s subsections
(*) USA Approval Date: 2020. 07.24
>Suspension for IV Infusion
CAR T Therapy
Company
Patent>Assignee; Claims; No.; Etc.
Patent>Total USA No.: 2
Patent>UpDate: 2020. 09.29.
TradeMark
TradeMark Web-Site

USA. G. Brexucabtagene Autoleucel>'s products
This section has no products